COntinuous Glucose Monitoring, Contingency Management, and Motivational InTerviewing for Patients With TypE 2 Diabetes in Kansas City

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is evaluating a behavioral treatment program that uses diabetes coaching and financial rewards in addition to continuous glucose monitoring to improve diabetes management in adult patients with type 2 diabetes. This study will evaluate if this behavioral treatment program increases individual adherence to a diabetes treatment plan and improves blood sugar management.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Diagnosed with type 2 diabetes

• Age 18 to 65

• Hemoglobin A1c (blood draw or point-of-care) test available within the last 3 months

• Most recent hemoglobin A1c result between 8.0 and 11.0

• Currently receiving treatment for diabetes by a licensed healthcare provider.

• Reliable access to a personal smart phone that is compatible with CGM

• English speaking

Locations
United States
Missouri
University of Missouri - Kansas City School of Medicine
RECRUITING
Kansas City
Contact Information
Primary
Carrie Kriz, MS
mckinleycr@umkc.edu
816-512-7473
Backup
Jared Bruce, PhD
brucejm@umkc.edu
816-235-1068
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 40
Treatments
Experimental: Behavioral Intervention with financial rewards and coaching
Individuals in the treatment group will receive financial rewards (contingency management) and diabetes coaching (motivational interviewing) in addition to wearing a continuous glucose monitor while receiving their usual diabetes treatment.
Active_comparator: Control
Individuals in the control group will not receive any interventions and will only wear a continuous glucose monitor while receiving their usual diabetes treatment.
Related Therapeutic Areas
Sponsors
Leads: University of Missouri, Kansas City

This content was sourced from clinicaltrials.gov